Mineral metabolism at pregnancy and its adequate correction

Authors

  • И. П. Мазур P.L. Shupik National Medical Academy of the Postgraduate Education, Ukraine https://orcid.org/0000-0001-9075-5041
  • Т. Ф Татарчук Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • В. А. Габаль P.L. Shupik National Medical Academy of the Postgraduate Education, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2016.27.36-40

Keywords:

mineral metabolism, bone metabolism, pregnancy, calcium, vitamin D

Abstract

Disorders of bone and mineral metabolism during gestation affect bone health in women (vitamin D and gestational diabetes, pre-eclampsia, infection associations with pregnancy are established) and fetus, leading to fetal growth retardation, low birth weight and birth children with symptoms of bone mineralization insufficiency. This is due to the calcium redistribution in pregnancy and prerequisites for changing bone mineral metabolism, that may lead to a decrease in bone mineral density, i.e. osteopenia.

It is proved that supplementation with calcium and vitamin D during pregnancy can significantly reduce the level of obstetrical and perinatal complications. Women who plan to become pregnant should start/continue to take vitamin D at doses as recommended for adults (200–2000 IU/day (20.0–50.0 mg/day) depending on body weight). Vitamin D at 1500–2000 IU/day (37.5–50.0 micrograms/day) is prescribed at least to II trimester. If possible, it is necessary to periodically monitor the 25(OH)D level in the blood serum to determine the optimal dose of the drug and test its effectiveness.

Prophylactic therapy should include pharmacological preparations containing a sufficient concentration of elemental calcium in the composition of high-salt biological availability.

Combination of calcium carbonate with physiological doses vitamin D is particularly advantageous, because the results of comparative observations showed calcium carbonate as a most effective and bioavailable form that makes it the drug of choice in pregnancy. Given the combination of nutrient deficiency of mineral and vitamin a Calcium-D3 Nycomed is a drug of choice. In pharmacoeconomic analysis and randomized multicentral clinical study this drug have been demonstrated efficacy and safety of long-term use, and high adherence to treatment by patients.

Author Biographies

И. П. Мазур, P.L. Shupik National Medical Academy of the Postgraduate Education

MD, professor of Dentistry Department, Institute of Dentistry

Т. Ф Татарчук, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, professor, corresponding member. NAMS of Ukraine, Deputy Director for Research, Head of Endocrine Gynecology

В. А. Габаль, P.L. Shupik National Medical Academy of the Postgraduate Education

Assistant of Dentistry Department, Institute of Dentistry

References

  1. Shurpiak, S.A., Zhemela, N.I. “Role of the minerals and vitamins balance in gestation process.” Women’s Health 5.91 (2014): 37–40.
  2. Obstetrics / Ed. by G.M. Savelieva. Moscow. Medicine (2000): 816 p.
  3. Arden, N.K., Major, P., Poole, J.R., et al. “Size at birth, adult intestinal calcium absorption and 1.25(OH) (2) vitamin D.” QJM : monthly journal of the Association of Physicians 95.1 (2002): 15–21.
  4. Li H., Hou, S., Wang, L., et al. “Relationship between calcium content and its character in fetal tissues and calcium deficiency of minor.” Wei Sheng Yan Jiu 3.5 (2003): 443–6.
  5. Strukov, V.I., Radchenko, L.G., Kamardina, L.V. “Rickets in children born in mothers with osteopenia.” Materials of Russian Osteoporosis Congress. Yaroslavl. Litera-M (2003): 95 p.
  6. Scheplyagina, L.A., Moiseeva, T.Y., Kruglova, I.V. “Reduced bone mineral density in children: pediatrician view.” Attending Doctor 9 (2002): 26–30.
  7. Hsu, S.C., Levine, M.A. “Perinatal calcium metabolism: physiology and pathophysiology.” Semin Neonatal 9.1 (2004): 23–36.
  8. Jones, G., Riley, M.D., Dwyer, T. “Maternal diet during pregnancy is associated with bone mineral dencity in children: a longitudinal study.” Eur J Clin Nutr 54.10 (2000): 749–56.
  9. Sokolova, M.Y. “Calcium deficiency during pregnancy.” Gynecology 5.5 (2004): 268–70.
  10. Namgung, R., Tsang, R.C. “Bone in the pregnant mother and newborn at birth.” Clin Chim Acta 333.1 (2003): 1–11.
  11. Shilin, D.E., Spirichev, V.B. “Mineral homeostasis and bone metabolism in the body of pregnant woman, fetus, baby.” Osteoporosis and osteopathy 2 (2006): 26–32.
  12. Gadieva, F.G. “Relationship of the immune and endocrine system in women of reproductive age.” Obstetrics and gynecology 1 (2001): 11–3.
  13. Wysolmerski, J.J. “The evolutionary origins of calcium and bone metabolism during lactation.” J Mammary Gland Biol Neoplasia 7.3 (2002): 267–76.
  14. Kovacs, C.S., Kronenberg, H.M. “Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Pucrpcrium, and Lactation.” Endocrine Reviews 18.6 (1997): 832–72.
  15. Prentice, A. “Maternal calcium metabolism and bone mineral status.” Am J Clin Nutr 71(Suppl) (2000): 1312S.
  16. Naylor, K.E., Iqbal, P., Fledelius, C., Fraser, R.B, Eastell, R. “The effect of pregnancy on bone density and bone turnover.” J Bone Miner Res 15.1 (2000): 129–37.
  17. Black, A.J., Topping, J., Durham, В., et al. “A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy.” J Bone Miner Res 15.3 (2000): 557–63.
  18. Root, A.W., Diamond, F.B. Jr. “Disorders of calcium metabolism in the child and adolescent.” // In: Pediatric endocrinology. Ed. by M.A. Sperling, 2nd ed. Saunders, Philadelphia (2002): 629–88.
  19. Villar, J., et al. “Methodological and technical issues related to the diagnosis, screening, prevention and treatment of pre-eclampsia and eclampsia.” International Journal of Gynecology and Obstetrics
  20. 1 (2004): 28–41.
  21. Hofmeyr, G.J., et al. “Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.” Cochrane Database Syst Rev 8 (2010): CD001059.
  22. Buppasiri, P., et al. “Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.” Cochrane Database Syst Rev 10 (2011): CD007079.
  23. Gasparyan, N.D., Logutova, L.S., Demina, E.B., et al. “Disorders of mineral metabolism and its correction with Calcium-D3 Nycomed in pregnant women with osteopenia.” Reproductive Women’s Health 5.34 (2007): 68–72.
  24. Pludowski, P., Povorozniuk, V., et al. “Guidelines for the treatment and prevention of vitamin D deficiency in the Central Europe population: recommended dose of vitamin D preparations for a healthy population and high-risk groups.” Pain. Joints. Spine 3 (2013): 75–96.
  25. Clinical guidelines. Osteoporosis. Diagnostics, prophylaxis and treatment / Ed. by L.I. Benevolenskaia, O.M. Lesniak. Moscow. GEOTAR-Media (2005): 176 p.

Downloads

Published

2016-04-05

How to Cite

Мазур, И. П., Татарчук, Т. Ф., & Габаль, В. А. (2016). Mineral metabolism at pregnancy and its adequate correction. REPRODUCTIVE ENDOCRINOLOGY, (27), 36–40. https://doi.org/10.18370/2309-4117.2016.27.36-40

Issue

No. 27 (2016)

Section

Pregnancy and childbirth

License

Copyright (c) 2016 И. П. Мазур, Т. Ф Татарчук, В. А. Габаль

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.